Jeremy Thomas Gaskins

Jeremy Thomas Gaskins

Auto-generated profile, based on publicly available information

Jeremy Thomas Gaskins

Department of Bioinformatics and Biostatistics University of Louisville Louisville Kentucky USA

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2020 in European Journal of Surgical Oncology
Verified
Journal Article
Closed access
SMSteven F. Mandish
Steven F. Mandish
JGJeremy T. Gaskins
Jeremy T. Gaskins
MYMehran B. Yusuf
Mehran B. Yusuf
BLBrendan P. Little
Brendan P. Little
NDNeal E. Dunlap
Neal E. Dunlap

20 December 2019 in BMC Bioinformatics
Verified
Journal Article
Open access
PDF file
JSJasmit Shah
Jasmit Shah
GBGuy Brock
Guy Brock
JGJeremy Gaskins
Jeremy Gaskins
Background: With the rise of metabolomics, the development of methods to address analytical challenges in the analysis of metabolomics data is of great importance. Missing values (MVs) are pervasive, yet the treatment of MVs can have a substantial impact on downstream statistical analyses. The MVs problem in metabolomics is quite challenging and can arise because the metabolite is not biologically present in the sample, or is present in the sample but at a concentration below the lower limit of detection (LOD), or is present in the sample but undetected due to technical issues related to sample pre-processing steps. The former is considered missing not at random (MNAR) while the latter is an example of missing at random (MAR). Typically, such MVs are substituted by a minimum value, which may lead to severely biased results in downstream analyses. Results: We develop a Bayesian model, called BayesMetab, that systematically accounts for missing values based on a Markov chain Monte Carlo (MCMC) algorithm that incorporates data augmentation by allowing MVs to be due to either truncation below the LOD or other technical reasons unrelated to its abundance. Based on a variety of performance metrics (power for detecting differential abundance, area under the curve, bias and MSE for parameter estimates), our simulation results indicate that BayesMetab outperformed other imputation algorithms when there is a mixture of missingness due to MAR and MNAR. Further, our approach was competitive with other methods tailored specifically to MNAR in situations where missing data were completely MNAR. Applying our approach to an analysis of metabolomics data from a mouse myocardial infarction revealed several statistically significant metabolites not previously identified that were of direct biological relevance to the study. Conclusions: Our findings demonstrate that BayesMetab has improved performance in imputing the missing values and performing statistical inference compared to other current methods when missing values are due to a mixture of MNAR and MAR. Analysis of real metabolomics data strongly suggests this mixture is likely to occur in practice, and thus, it is important to consider an imputation model that accounts for a mixture of missing data types.


16 April 2020 in Scandinavian Journal of Statistics
Verified
Journal Article
Closed access
PDF file
DKDebamita Kundu
Debamita Kundu
RMRiten Mitra
Riten Mitra
JGJeremy T. Gaskins
Jeremy T. Gaskins

1 January 2021 in Brachytherapy
Verified
Journal Article
Closed access
LRLeonid B. Reshko
Leonid B. Reshko
JGJeremy T. Gaskins
Jeremy T. Gaskins
DMDaniel S. Metzinger
Daniel S. Metzinger
STSarah L. Todd
Sarah L. Todd
HEHarriet B. Eldredge-Hindy
Harriet B. Eldredge-Hindy
SSScott R. Silva
Scott R. Silva

18 August 2020 in BMC Bioinformatics
Verified
Journal Article
Open access
PDF file
MSMichael Sekula
Michael Sekula
JGJeremy Gaskins
Jeremy Gaskins
SDSusmita Datta
Susmita Datta
Background: Gene co-expression networks (GCNs) are powerful tools that enable biologists to examine associations between genes during different biological processes. With the advancement of new technologies, such as single-cell RNA sequencing (scRNA-seq), there is a need for developing novel network methods appropriate for new types of data.Results: We present a novel sparse Bayesian factor model to explore the network structure associated with genes in scRNA-seq data. Latent factors impact the gene expression values for each cell and provide flexibility to account for common features of scRNA-seq: high proportions of zero values, increased cell-to-cell variability, and overdispersion due to abnormally large expression counts. From our model, we construct a GCN by analyzing the positive and negative associations of the factors that are shared between each pair of genes.Conclusions: Simulation studies demonstrate that our methodology has high power in identifying gene-gene associations while maintaining a nominal false discovery rate. In real data analyses, our model identifies more known and predicted protein-protein interactions than other competing network models.